ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $377,000 | +60.4% | 20,000 | 0.0% | 0.03% | +58.8% |
| Q2 2019 | $235,000 | -13.9% | 20,000 | 0.0% | 0.02% | -22.7% |
| Q1 2019 | $273,000 | +131.4% | 20,000 | +73.9% | 0.02% | +57.1% |
| Q4 2018 | $118,000 | -38.2% | 11,500 | 0.0% | 0.01% | -26.3% |
| Q3 2018 | $191,000 | +4.9% | 11,500 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $182,000 | +24.7% | 11,500 | 0.0% | 0.02% | +26.7% |
| Q1 2018 | $146,000 | +10.6% | 11,500 | 0.0% | 0.02% | +7.1% |
| Q4 2017 | $132,000 | -30.2% | 11,500 | -25.4% | 0.01% | -36.4% |
| Q3 2017 | $189,000 | – | 15,406 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |